Printing system for carrying out energy conservation operation

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Minolta Co., Ltd. patent solves the following problem:

This invention relates to a printer, the data processor, printing system, printer control method, the data processor processing methods, programs, data processing programs and the recording media to the program on record, and especially in a printer, a data processor, printing system, printer control method, the data processor processing procedures, programs, data processing program and recording media on recorded programs to bring in an energy-conservation operations.

Our analysis of this patent is as follows:

Minolta Co., Ltd.’s patent US 6807907 B2 deals with Printing system for carrying out energy conservation operation.
A printer 100 sends status information, ID information and the like in a network device 200 enters an energy conservation strategy that it is not communicate with external devices, so the network device 200 to respond to a request status information for her. Where a PC 300 requests status information from the printer 100, the network device 200 instead of reaction conditions put in effect answered by the printer 100 status information for the printer 100 by receiving the response status from the network device 200, the PC 300 can check that the printer connected to the network 400. the PC 300 can also send a release that brought the printer 100 from the state energy conservation to be set printing.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Preparations containing folic acid and a natural isomer of a reduced folate

File for Quick & Easy Patent Protection with PowerPatent.

The South Alabama Medical Science Foundation patent solves the following problem:

The folates are ubiquitous to nearly all forms of life. Humans and many other animals lack the capacity to make their own folate which thus is an important vitamin, a kind of important nurient. Anemia especially during pregnancy and geriatric population was an early indication of a dietary requirement for folate. A major function of folate is to remove the unit in a carbon from the molecule metabolized and then deliver them to the molecules synthesized. As an example, folate participates in the building of nucleic acid. Furthermore, the activity of DNA controlled, in part, by methylation, and the primary methylating agent in the body (S-adenosylmethionine) made a metabolic cycle involving a folate. Many studies, therefore, focus on the relationship of folate status to cancer susceptibility, especially colorectal adenoma.

Our analysis of this patent is as follows:

South Alabama Medical Science Foundation’s patent US 6808725 B2 deals with Preparations containing folic acid and a natural isomer of a reduced folate.
Disclosed is a composition that includes one or more natural isomers of reduced folate selected from the group consisting of (6S) -tetrahydrofolic acid, 5-methyl- (6S) -tetrahydrofolic acid, 5-formyl – (6S) -tetrahydrofolic acid, 10 -formyl- (6R) -tetrahydrofolic acid, 5,10-methylene- (6R) -tetrahydrofolic acid, 5,10-methenyl- (6R) -tetrahydrofolic acid, 5-formimino- ( 6S) -tetrahydrofolic acid, and polyglutamyl derivatives thereof; and an important nutrient preparations containing folic acid and a vitamin other than ascorbic acid. also disclosed is a composition that contains folic acid and one or more natural isomers of reduced folate selected from the group consisting of (6S) -tetrahydrofolic acid, 5-methyl- (6S) -tetrahydrofolic acid , 5-formyl- (6S) – tetrahydrofolic acid, 10-formyl- (6R) -tetrahydrofolic acid, 5,10-methylene- (6R) -tetrahydrofolic acid, 5,10-methenyl- (6R) -tetrahydrofolic acid, 5 -formimino- (6S) -tetrahydrofolic acid, and polyglutamyl derivatives thereof; as well as a composition that includes 5-methyltetrahydrofolic acid and folic acid.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Technical field

File for Quick & Easy Patent Protection with PowerPatent.

The Yamanouchi Pharmaceutical Co., Ltd., , Yamanouchi Pharma Technologies, Inc. patent solves the following problem:

As for pharmaceutical dosage form for oral use, a tablet, a capsule, a granule, a powder and the like are mentioned. However, these dosage forms have some issues if a patient takes them. For example, on a tablet or a capsule, if the patient is a man of advanced age or a child, there are some cases that they love getting the pharmaceutical preparation because it is difficult for them, to destroy them or to prepare stick in the throat or esophagus. Furthermore, part of a granule or a powder, in some cases they love getting preparations under the reason that it is difficult for them, to destroy them with his stay in buccal hole or the reason that they choke when taking the dose. From a compliance to take the pharmaceutical preparation is tumbling in the case, it intends to take the easy pharmaceutical dosage forms, and as a result of a broken preparation buccal cavity being studied and developed.

Our analysis of this patent is as follows:

Yamanouchi Pharmaceutical Co., Ltd., , Yamanouchi Pharma Technologies, Inc.’s patent US 6803054 B2 deals with Technical field.
The present invention relates to a quick disintegrating tablets in the buccal cavity, comprising: a mixture, consisting of a drug, a sugar (A), and is similar to an amorphous sugar (B) , and after building a tablet, it is humidified and dried. In particular, the present invention relates to a quick disintegrating tablets in the buccal cavity comprising: a mixture; consisting of a drug, a sugar (A), and is similar to an amorphous sugar (B) amounting to an amorphous-forming sugar crystals had dissolved to a treatment permitted solvent, the amorphous sugar extracted from the solution by removing to be, and after the formation of a board, and it is humidified and dried. The tablets of the present invention is to provide stability against moisture stored, because the amorphous sugar changed the crystalline state in a nonreversible reaction after it is humidified and dried in a manufacturing process. The tablets of the present invention is further to provide a design for the pharmaceutical preparation with respect to the strength of a drug, because the tablets produced in a form of a sugar and similar amorphous sugar. Furthermore, the tablets of the present invention is to provide a production process by using a common granulating machine and through the use of a common tablet machine.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Secreted factors

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Scios Inc. patent solves the following problem:

Gene expression pattern, including changes in gene expression between normal and diseased tissues or tissues in various stages of disease development to provide valuable insight into the molecular determinants normal and not normal cellular physiology. Therefore, genes differentially expressed in subjects suffering from a disease, such as heart, bladder or inflammatory disease, relative to normal subjects, the useful target for intervention to diagnose, prevent or treat such diseases.

Our analysis of this patent is as follows:

Scios Inc.’s patent US 6800455 B2 deals with Secreted factors.
The invention concerns a new hidden factors encoded in clones P00184_D11 (SEQ ID NO: 1), P00185_D11 (SEQ ID NO: 3), P00188_D12 (SEQ ID NO: 5), P00188_E01 (SEQ ID NO: 7), P00194_G01 (SEQ ID NO: 9), P00194_G05 (SEQ ID NO: 11), P00194_H10 (SEQ ID NO: 13), P00199_D08 (SEQ ID NO: 15), P00203_D04 (SEQ ID NO: 17), P00203_E06 (SEQ ID NO: 19), P00209_F06 (SEQ ID NO: 21), P00219_D02 (SEQ ID NO: 23), P00219_F06 (SEQ ID NO: 25), P00220_H05 (SEQ ID NO: 27), P00222_G03 (SEQ ID NO: 29), P00225_C01 ( SEQ ID NO: 32), P00227_D11 (SEQ ID NO: 34), P00228_F03 (SEQ ID NO: 36), P00233_H08 (SEQ ID NO: 38), P00235_G08 (SEQ ID NO: 40), P00239_C11 (SEQ ID NO: 42 ), P00240_E05 (SEQ ID NO: 45), P00247_A04 (SEQ ID NO: 50), P00248_B04 (SEQ ID NO: 52), P00249_F09 (SEQ ID NO: 54), P00258_A10 (SEQ ID NO: 56), P00262_C10 (SEQ ID NO: 58), P00269_H08 (SEQ ID NO: 62), P00628_H02 (SEQ ID NO: 66), P00629_C08 (SEQ ID NO: 68), P00641_G11 (SEQ ID NO: 71), P00648_E12 (SEQ ID NO: 73) P00697_C03 (SEQ ID NO: 75), and other mammal homologues and variants in the matter, as well as polynucleotides encoding them. invention further ways and means for the production of such factors and their use in the diagnosis and treatment of various heart, bladder or inflammatory diseases.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Device for dispensing viscous liquids

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Gopro, Inc. patent solves the following problem:

This whole creation-related devices used to dispense viscous fluids such as hot melt adhesives and sealing compounds. Such devices can be applied to fluid control valves or dispensing guns or modules. More particularly, the present invention relates to a valve for dispensing hot melt adhesives and other viscous liquids that have flourished partly related to increasing reliability and performance while retaining the user's ability to adjust, healing and reconstruction schemes.

Our analysis of this patent is as follows:

Gopro, Inc.’s patent US 6799702 B1 deals with Device for dispensing viscous liquids.
A liquid delivery device including a body generally has an air passage and a liquid passage. A valve-seat body and connected to a valve stem mounted for movement in the body with respect to the valve seat. A piston causes the movement of the pressurized air, and for a spring and optionally, the air pressure on the piston, to return to its normal position when the air pressure is relieved. stick connected to the piston so that it is caused to move linearly to and from the valve seat. Stem rigidly connected to the piston, allowing the piston to find its center air cylinder and the stem to find its center in the liquid chamber. piston mounted with two points of birth is that it is not affected by uneven pressure in the spring. Stem was two points with childbirth, the adhesive seal and seat. The air cylinder body and valve body away in a large open area. The body includes a user replaceable cylindrical filter disposed liquid chamber around the stem. This filter and the liquid seal is easily removed for maintenance to get the seal housing from the bottom of the valve.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.